1,3,4-oxadiazole has been researched along with 2,4-thiazolidinedione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, MM; Alam, MS; Alam, P; Ali, Y; Bano, S; Dhulap, A; Haider, S; Hamid, H; Kharbanda, C; Nazreen, S; Pasha, MA; Pillai, KK; Shafi, S; Yar, MS | 1 |
| Alam, MM; Alzhrani, ZMM; Nazreen, S; Neamatallah, T | 1 |
2 other study(ies) available for 1,3,4-oxadiazole and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
Topics: Animals; Blood Glucose; Computer Simulation; Diabetes Mellitus, Experimental; Drug Design; Female; Gene Expression Regulation; Glucose Tolerance Test; HEK293 Cells; Humans; Hypoglycemic Agents; Liver; Male; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones | 2014 |
Design, synthesis and
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Thiazolidinediones; Thymidylate Synthase | 2020 |